$--
(Market cap
--
Recently Viewed
Clear AllMarket cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
--
ROE
--
ROCE
--
Industry P/E
--
EV/EBITDA
--
Debt to Equity
--
Book Value
--
EPS
--
Face value
--
Shares outstanding
--
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biora Therapeutics, Inc (BIORQ)
| -- | -- | -- | -100.0 | -99.7 | -98.4 | -- |
|
BSE Sensex*
| -9.2 | 1.1 | -8.4 | 2.2 | 8.4 | 9.9 | 11.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal... tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On May 27, 2025, the voluntary petition of Biora Therapeutics, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on December 27, 2024. Read more
CEO & Director
Mr. Aditya P. Mohanty M.B.A.
CEO & Director
Mr. Aditya P. Mohanty M.B.A.
Headquarters
San Diego, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Biora Therapeutics, Inc (BIORQ) is $0.00 (NASDAQ) as of 10-Apr-2026 11:36 EDT. Biora Therapeutics, Inc (BIORQ) has given a return of -99.67% in the last 3 years.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
-0.16
|
-0.20
|
|
2022
|
0.00
|
0.00
|
|
2021
|
-0.01
|
-0.02
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
The 52-week high and low of Biora Therapeutics, Inc (BIORQ) are Rs 0.34 and Rs 0.00 as of 13-Apr-2026.
Biora Therapeutics, Inc (BIORQ) has a market capitalisation of -- as on 10-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Biora Therapeutics, Inc (BIORQ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.